Epidermal growth factor receptor tyrosine kinase inhibitors in patients with EGFR wild-type lung cancer: when there is a target, there is a targeted drug

J Clin Oncol. 2015 Feb 10;33(5):523-4. doi: 10.1200/JCO.2014.57.5449. Epub 2015 Jan 12.

Authors

Fei Zhou¹, Xiaoxia Chen¹, Caicun Zhou²

Affiliations

¹ Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.
² Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China [email protected].

PMID: 25584007
DOI: 10.1200/JCO.2014.57.5449

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Agents / therapeutic use*
Carcinoma, Non-Small-Cell Lung / drug therapy*
Female
Humans
Lung Neoplasms / drug therapy*
Male
Quinazolines / therapeutic use*
Taxoids / therapeutic use*

Substances

Antineoplastic Agents
Quinazolines
Taxoids